| |
|
|
|
| Understanding the therapeutic uses of cannabinoids in pain and symptoms management |
| Back to conference list |
| Speaker: |
Apr 23, 2009 |
 |
Dr. Mark A. Ware MBBS MRCP(UK) MSc
Executive Director
Canadian Consortium for the Investigation of Cannabinoids
Assistant Professor, Anesthesia/Family Medicine
MUHC Pain Centre
McGill |
Dr. Ware will be joining the forum. For section 1 accreditation you must interact on the forum. |
|
Title:
Understanding the therapeutic uses of cannabinoids in pain and symptoms management |
Description:
A discussion of the basic concepts of cannabinoid neurophysiology, the clinical trial evidence of cannabinoids in chronic disease management, the assess the risks and benefits of existing pharmaceutical cannabinoid preparations
and the attitudes towards the use of cannabis and cannabinoids in clinical practice. |
Keywords:
pain, McGill, cannabinoids, marijuana, THC, Cannabidio, Nabilone, Anandamide, CB1, CB2 |
Categories:
Pain/Douleur; Anesthesia/Anesthesia; Pharmacology/Pharmacologie; CCIC; Inhalation Therapy/Inhalothérapie; |
| Accreditation (4): Click here for details |
|
|
 |
|
You must login to view this conference
|
| |
|
|
|
|
|
| 2013 McGill University - Continuing Health Professional Education (CHPE) |
|
|
|